세포 배양 시장 : 2028년까지의 세계 예측

조사회사 : MarketsandMarkets (마켓츠앤마켓츠)   출판년월 : 2024년03월

Cell Culture Market – Global Forecast to 2029

세포 배양 시장 : 제품[소모품(미디어, 혈청, 시약), 용기(롤러 병, 세포 공장, 플라스크), 기기(SU 바이오리액터, 보관, 인큐베이터, 여과)], 용도(mAbs, 백신, 재생의료 ) – 2029년까지의 세계 예측
Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) – Global Forecast to 2029

　　　　주문/문의　　　　조사회사/라이센스/납기안내

Report Overview

The cell culture market is projected to reach USD 57.9 billion by 2029 from an estimated USD 30.9 billion in 2024, at a CAGR of 13.4% during the forecast period of 2024 to 2029.

세포 배양 시장은 2024년부터 2029년까지 예측 기간 동안 연평균 복합 성장률(CAGR) 13.4%로 성장해, 2024년 약 309억 달러 규모에서 2029년에는 579억 달러 규모에 이를 것으로 예상됩니다.

The growth of this market can be attributed to growing investments and fundings for research in the field of cell biology. The rising incidence of chronic diseases such as cancer is boosting the demand for advanced therapies such as tissue engineering, and regenerative medicine. This trend is expected to drive the growth of the cell culture market in the coming years.

“The biopharmaceutical production segment accounted for the largest share of by application segment in 2023.”
In 2023, the biopharmaceutical production segment accounted for the largest share of by application segment in the global cell culture market. Biopharmaceutical production segment is further categorized into vaccine production, monoclonal antibody production, and other therapeutic protein production. The growing prevalence of infectious diseases is boosting the demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and therapeutic proteins, resulting to promote the growth of biopharmaceutical production in cell culture market.

“The US will continue to dominate the cell culture market during the forecast period of 2024-2029.”
In 2023, the cell culture market in North America was led by the US. As the world’s largest biopharmaceutical market with a strong emphasis on research and investment in biopharmaceuticals, the US holds a prominent position. Moreover, the country hosts renowned academic research institutions such as Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT), renowned for their groundbreaking work in life sciences, including drug discovery and biotechnology, which extensively employ cell culture techniques, thereby fuelling market expansion. Furthermore, increasing investments in tissue engineering and regenerative medicine R&D are contributing to the growth of the cell culture market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America – 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Merck KGaA (Germany)
• Corning Incorporated (US)
• FUJIFILM Holdings Corporation (Japan)
• BD (US)
• Eppendorf SE (Germany)
• Lonza (Switzerland)
• Getinge AB (Sweden)
• Agilent Technologies, Inc. (US)
• HiMedia Laboratories (India)
• Miltenyi Biotec (Germany)
• STEMCELL Technologies (Canada)
• Solida Biotech GmbH (Germany)
• Caisson Labs (US)
• PromoCell GmbH (Germany)
• InvivoGen (France)
• PAN-Biotech (Germany)
• Cellexus (Scotland)
• Meissner Filtration Products Inc. (US)
• Adolf Kühner AG (Switzerland)
• Bio-Techne (US)
• Advancion Corporation (US)
• BioSpherix, Ltd. (US)

Research Coverage:
This research report categorizes the cell culture market by product ((equipment (bioreactors, storage equipment, and other equipment), consumables (sera, media, reagents, vessels, and accessories)), by application (biopharmaceutical production (vaccine production, monoclonal antibody production, and other therapeutic protein production), diagnostics, tissue engineering & regenerative medicine (cell & gene therapy and other tissue engineering & regenerative medicine applications), drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell culture market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the cell culture market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of infectious diseases, rising adoption of single-use technologies, and growing strategic alliances for the development of advanced therapy medicine products), restraints (high cost of cell biology research and limitations regarding production of high density cell culture), opportunities (growing opportunities in emerging economies, rising demand for 3D cell culture), and Challenges (ethical concern regarding cell usage) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the cell culture market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell culture market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US), among others in the market.

Table of Contents

1            INTRODUCTION            88

1.1         STUDY OBJECTIVES      88

1.2         MARKET DEFINITION   88

1.2.1      INCLUSIONS AND EXCLUSIONS OF STUDY         89

1.3         MARKET SCOPE             90

1.3.1      MARKETS COVERED     90

1.3.2      REGIONS COVERED      91

1.4         YEARS CONSIDERED     91

1.5         CURRENCY        92

1.5.1      VALUE UNIT     92

1.5.2      VOLUME UNIT 92

1.6         STAKEHOLDERS            92

1.7         LIMITATIONS   92

1.8         SUMMARY OF CHANGES            93

1.9         RECESSION IMPACT      94

2            RESEARCH METHODOLOGY     95

2.1         RESEARCH DATA           95

FIGURE 1           RESEARCH DESIGN       95

2.1.1      SECONDARY DATA       96

2.1.2      PRIMARY DATA 97

FIGURE 2           BREAKDOWN OF PRIMARIES: CELL CULTURE MARKET 97

2.2         MARKET ESTIMATION METHODOLOGY            98

FIGURE 3           CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023             98

2.2.1      BOTTOM-UP APPROACH           98

FIGURE 4           MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023             99

FIGURE 5           ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023) 99

2.2.2      INSIGHTS FROM PRIMARY EXPERTS      101

FIGURE 6           MARKET SIZE VALIDATION FROM PRIMARY SOURCES  101

2.2.3      TOP-DOWN APPROACH             101

FIGURE 7           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       101

2.3         MARKET GROWTH RATE PROJECTIONS             103

FIGURE 8           CELL CULTURE MARKET (SUPPLY-SIDE): CAGR PROJECTIONS              103

TABLE 1             IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS           104

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    106

FIGURE 9           DATA TRIANGULATION METHODOLOGY         106

2.5         RESEARCH ASSUMPTIONS         107

2.6         RISK ANALYSIS 107

2.7         RECESSION IMPACT ANALYSIS 108

3            EXECUTIVE SUMMARY 110

FIGURE 10         CELL CULTURE MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)          110

FIGURE 11         CELL CULTURE MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)          111

FIGURE 12         CELL CULTURE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)          111

FIGURE 13         GEOGRAPHICAL SNAPSHOT OF CELL CULTURE MARKET              112

4            PREMIUM INSIGHTS      113

4.1         CELL CULTURE MARKET OVERVIEW     113

FIGURE 14         INCREASING APPROVALS AND LAUNCHES OF BIOLOGICAL DRUGS TO SUPPORT MARKET GROWTH           113

4.2         NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT AND COUNTRY (2023)           114

FIGURE 15         CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023      114

4.3         CELL CULTURE MARKET SHARE, BY APPLICATION, 2023            114

FIGURE 16         BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023     114

4.4         CELL CULTURE MARKET SHARE, BY END USER, 2023     115

FIGURE 17         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED END-USER MARKET IN 2023      115

4.5         CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              115

FIGURE 18         ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD     115

5            MARKET OVERVIEW     116

5.1         INTRODUCTION            116

5.2         MARKET DYNAMICS     116

FIGURE 19         CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    116

TABLE 2             CELL CULTURE MARKET: IMPACT ANALYSIS    117

5.2.1      DRIVERS            117

5.2.1.1   Increasing support and funding from government and private organizations for cell-based research            117

TABLE 3             NIH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION) 118

TABLE 4             FUNDING INVESTMENTS IN CELL & GENE THERAPY     119

5.2.1.2   Emerging cell culture technologies for production of cell-based viral vaccines              120

5.2.1.3   Growing popularity of monoclonal antibodies and biosimilars    121

TABLE 5             COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2023     121

FIGURE 20         NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU (2012−2023)          122

FIGURE 21         NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED (2015−2024)      123

5.2.1.4   Adoption of single-use technologies 123

5.2.1.5   Growing focus of key players on product launches        123

5.2.1.6   Growth in advanced therapy medicinal products          124

FIGURE 22         CLINICAL TRIALS OVERVIEW OF TISSUE-ENGINEERED PRODUCTS (2019–2023) 125

5.2.1.7   Increasing incidence of infectious diseases     126

FIGURE 23         GLOBAL HIV EPIDEMIC, 2022    127

5.2.2      RESTRAINTS     127

5.2.2.1   High cost of cell biology research     127

5.2.2.2   Limitations in producing high-density cell cultures      128

5.2.3      OPPORTUNITIES           128

5.2.3.1   Rising demand for 3D cell cultures   128

5.2.3.2   Emerging economies offer lucrative growth opportunities          129

TABLE 6             ASIA PACIFIC PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2023          130

5.2.3.3   Increasing focus on next-generation therapeutics         130

FIGURE 24         RSV VACCINE AND MAB SNAPSHOT (AS OF JANUARY 2024)              131

5.2.4      CHALLENGES   132

5.2.4.1   Disposal of plastic consumables       132

TABLE 7             COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS      132

5.2.4.2   Ethical concerns related to cell usage             133

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS     134

FIGURE 25         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS              135

5.4         PRICING ANALYSIS        135

5.4.1      AVERAGE SELLING PRICE OF CELL CULTURE EQUIPMENT AND CONSUMABLES 135

TABLE 8             AVERAGE SELLING PRICE RANGE OF CELL CULTURE EQUIPMENT AND CONSUMABLES, BY KEY PLAYER        135

5.4.2      AVERAGE SELLING PRICE OF CELL CULTURE PRODUCTS, BY REGION              136

TABLE 9             AVERAGE SELLING PRICE RANGE OF SINGLE-USE ASSEMBLIES, BY REGION        136

TABLE 10           AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000L IN DEVELOPED AND DEVELOPING COUNTRIES (2023)     136

5.5         TECHNOLOGY ANALYSIS           137

5.5.1      KEY TECHNOLOGIES    137

5.5.1.1   Single-use technology        137

TABLE 11           ADVANTAGES OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS 138

5.5.1.2   Flow cytometry    139

5.5.1.3   Microscopy          139

5.5.2      COMPLEMENTARY TECHNOLOGIES     139

5.5.2.1   High-throughput screening              139

5.5.2.2   Mass spectrometry             139

5.5.3      ADJACENT TECHNOLOGIES      139

5.5.3.1   Microfluidics and organ-on-a-chip   139

TABLE 12           ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE          140

5.5.3.2   3D bioprinting     140

5.6         TRADE DATA    141

TABLE 13           IMPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)     141

TABLE 14           EXPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)     146

TABLE 15           IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS) 148

TABLE 16           EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS) 152

5.7         PATENT ANALYSIS        154

5.7.1      METHODOLOGY           154

5.7.2      PATENTS FILED, BY DOCUMENT TYPE, 2014–2024          154

TABLE 17           PATENTS FILED, 2014–2024        154

5.7.3      INNOVATION AND PATENT APPLICATIONS      154

FIGURE 26         TOTAL NUMBER OF PATENTS GRANTED, 2014–2024      154

5.7.4      TOP APPLICANTS          155

FIGURE 27         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024         155

TABLE 18           TOP 20 PATENT OWNERS IN CELL CULTURE, 2014–2024 155

TABLE 19           INDICATIVE LIST OF PATENTS IN CELL CULTURE MARKET, 2022–2024          156

5.8         VALUE CHAIN ANALYSIS            158

FIGURE 28         VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE       158

5.9         SUPPLY CHAIN ANALYSIS          160

FIGURE 29         CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS      160

5.10       ECOSYSTEM ANALYSIS 161

FIGURE 30         CELL CULTURE MARKET: ECOSYSTEM ANALYSIS           161

5.10.1    CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS  161

TABLE 20           CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS              161

5.10.2    CELL CULTURE MARKET: ROLE OF PRODUCT PROVIDERS        162

TABLE 21           CELL CULTURE MARKET: ROLE OF PRODUCT PROVIDERS              162

5.10.3    CELL CULTURE MARKET: ROLE OF END USERS 162

TABLE 22           CELL CULTURE MARKET: ROLE OF END USERS 162

5.10.4    CELL CULTURE MARKET: ROLE OF REGULATORY AUTHORITIES              163

TABLE 23           CELL CULTURE MARKET: ROLE OF REGULATORY AUTHORITIES  163

5.11       PORTER’S FIVE FORCES ANALYSIS         163

TABLE 24           CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS              163

5.11.1    THREAT OF NEW ENTRANTS    163

5.11.2    THREAT OF SUBSTITUTES         164

5.11.3    BARGAINING POWER OF SUPPLIERS     164

5.11.4    BARGAINING POWER OF BUYERS           164

5.11.5    INTENSITY OF COMPETITIVE RIVALRY 164

5.12       REGULATORY LANDSCAPE       165

5.12.1    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          165

TABLE 25           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         165

TABLE 26           EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         165

TABLE 27           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         167

TABLE 28           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         167

5.12.2    REGULATORY SCENARIO           168

TABLE 29           CELL CULTURE MARKET: REGULATORY GUIDELINES   168

5.13       KEY CONFERENCES & EVENTS, 2024–2025           171

TABLE 30           CELL CULTURE MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024–2025        171

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    172

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         172

FIGURE 31         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL CULTURE PRODUCTS      172

5.14.2    BUYING CRITERIA FOR CELL CULTURE 173

FIGURE 32         KEY BUYING CRITERIA FOR END USERS              173

TABLE 31           BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER    173

5.15       INVESTMENT AND FUNDING SCENARIO            174

6            CELL CULTURE MARKET, BY PRODUCT             176

6.1         INTRODUCTION            177

TABLE 32           CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          177

6.2         CONSUMABLES 177

TABLE 33           CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)              177

TABLE 34           CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)          178

TABLE 35           NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          178

TABLE 36           EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179

TABLE 37           ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     179

TABLE 38           LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          180

TABLE 39           MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)     180

TABLE 40           GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          180

6.2.1      SERA, MEDIA, AND REAGENTS  181

TABLE 41           SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 181

TABLE 42           SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 181

TABLE 43           NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    182

TABLE 44           EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    182

TABLE 45           ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    183

TABLE 46           LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    183

TABLE 47           MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)       184

TABLE 48           GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    184

6.2.1.1   Media    184

TABLE 49           MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)    185

TABLE 50           MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)              186

TABLE 51           MEDIA MARKET, BY REGION, 2022-2029 (MILLION LITERS)              186

TABLE 52           NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186

TABLE 53           EUROPE: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 54           ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 55           LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188

TABLE 56           MIDDLE EAST: MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)          188

TABLE 57           GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188

6.2.1.1.1 Serum-free media 189

6.2.1.1.1.1           Serum-free media to hold largest market share             189

TABLE 58           SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS              189

TABLE 59           SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)          190

TABLE 60          NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          190

TABLE 61           EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     191

TABLE 62           ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          191

TABLE 63           LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          192

TABLE 64           MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)          192

TABLE 65           GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          192

6.2.1.1.2 Classical media & salts       193

6.2.1.1.2.1           Increased usage of classical media and salts for efficient and scalable vaccine production to drive segment growth  193

TABLE 66           CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS           193

TABLE 67           CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION) 194

TABLE 68           NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    194

TABLE 69           EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          195

TABLE 70           ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    195

TABLE 71           LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    196

TABLE 72           MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION)       196

TABLE 73           GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    196

6.2.1.1.3 Stem cell culture media      197

6.2.1.1.3.1           Funding and grants for stem cell-based research and therapies to drive market   197

TABLE 74           STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS           197

TABLE 75           STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 197

TABLE 76           NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    198

TABLE 77           EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          198

TABLE 78           ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    199

TABLE 79           LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    199

TABLE 80           MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)       200

TABLE 81           GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    200

6.2.1.1.4 Chemically defined media  200

6.2.1.1.4.1           Rising need for reproducibility, regulatory compliance, and precise control in cell culture systems to support growth          200

TABLE 82           CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS           201

TABLE 83           CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 201

TABLE 84           NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    202

TABLE 85           EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    202

TABLE 86           ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    203

TABLE 87           LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    203

TABLE 88           MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)       204

TABLE 89           GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    204

6.2.1.1.5 Specialty media    204

6.2.1.1.5.1           Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost adoption            204

TABLE 90           SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS 205

TABLE 91           SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)          205

TABLE 92           NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          206

TABLE 93           EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206

TABLE 94           ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     207

TABLE 95           LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          207

TABLE 96           MIDDLE EAST: SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)     207

TABLE 97           GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          208

6.2.1.1.6 Other media        208

TABLE 98           OTHER MEDIA OFFERED BY KEY MARKET PLAYERS      209

TABLE 99           OTHER MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)              209

TABLE 100         NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          210

TABLE 101         EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210

TABLE 102         ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     211

TABLE 103         LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     211

TABLE 104         MIDDLE EAST: OTHER MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 211

TABLE 105         GCC COUNTRIES: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     212

6.2.1.2   Reagents              212

TABLE 106         REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)              213

TABLE 107         REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)              213

TABLE 108         NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     214

TABLE 109         EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          214

TABLE 110         ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215

TABLE 111         LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215

TABLE 112         MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 215

TABLE 113         GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     216

6.2.1.2.1 Growth factors     216

6.2.1.2.1.1           Growth factors to hold largest share of reagents market             216

TABLE 114         GROWTH FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)          217

TABLE 115         NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          217

TABLE 116         EUROPE: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     218

TABLE 117         ASIA PACIFIC: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          218

TABLE 118         LATIN AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          219

TABLE 119         MIDDLE EAST: GROWTH FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)     219

TABLE 120         GCC COUNTRIES: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          219

6.2.1.2.2 Supplements        220

6.2.1.2.2.1           Acquisitions and expansions by key cell culture vendors to drive growth              220

TABLE 121         SUPPLEMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          220

TABLE 122         NORTH AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          221

TABLE 123         EUROPE: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 221

TABLE 124         ASIA PACIFIC: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     222

TABLE 125         LATIN AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     222

TABLE 126         MIDDLE EAST: SUPPLEMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 222

TABLE 127         GCC COUNTRIES: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          223

6.2.1.2.3 Buffers & chemicals           223

6.2.1.2.3.1           Wide usage in cell cultures to promote market growth  223

TABLE 128         BUFFERS & CHEMICALS MARKET, BY REGION, 2022–2029 (USD MILLION)          224

TABLE 129         NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    224

TABLE 130         EUROPE: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          225

TABLE 131         ASIA PACIFIC: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          225

TABLE 132         LATIN AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    226

TABLE 133         MIDDLE EAST: BUFFERS & CHEMICALS MARKET, BY REGION, 2022–2029 (USD MILLION)          226

TABLE 134         GCC COUNTRIES: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    226

6.2.1.2.4 Cell dissociation reagents   227

6.2.1.2.4.1           Ability to efficiently and gently detach adherent cells from culture surfaces to boost demand for dissociation reagents       227

TABLE 135         CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)     227

TABLE 136         NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            228

TABLE 137         EUROPE: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    228

TABLE 138         ASIA PACIFIC: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    229

TABLE 139         LATIN AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    229

TABLE 140         MIDDLE EAST: CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)       230

TABLE 141         GCC COUNTRIES: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            230

6.2.1.2.5 Balanced salt solutions       230

6.2.1.2.5.1           Ability to maintain optimal physiological conditions for cell growth and experimentation to drive segment growth      230

TABLE 142         BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 231

TABLE 143         NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    231

TABLE 144        EUROPE: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          232

TABLE 145         ASIA PACIFIC: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    232

TABLE 146         LATIN AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    233

TABLE 147         MIDDLE EAST: BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)       233

TABLE 148         GCC COUNTRIES: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    233

6.2.1.2.6 Attachment & matrix factors            234

6.2.1.2.6.1           Rising adoption of 3D cell culture models to support market growth              234

TABLE 149         ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)          234

TABLE 150         NORTH AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         235

TABLE 151         EUROPE: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    235

TABLE 152         ASIA PACIFIC: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    236

TABLE 153         LATIN AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            236

TABLE 154         MIDDLE EAST: ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)  237

TABLE 155        GCC COUNTRIES: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            237

6.2.1.2.7 Antibiotics/Antimycotics   237

6.2.1.2.7.1           Risk of contamination to make use of antibiotics/antimycotics essential              237

TABLE 156         ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 238

TABLE 157         NORTH AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    238

TABLE 158         EUROPE: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    239

TABLE 159         ASIA PACIFIC: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    239

TABLE 160         LATIN AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    240

TABLE 161         MIDDLE EAST: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)       240

TABLE 162         GCC COUNTRIES: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    240

6.2.1.2.8 Cryoprotective reagents     241

6.2.1.2.8.1           Ability to preserve cell viability during freezing and thawing to boost demand 241

TABLE 163         CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 241

TABLE 164         NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    242

TABLE 165         EUROPE: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    242

TABLE 166         ASIA PACIFIC: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    243

TABLE 167         LATIN AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    243

TABLE 168         MIDDLE EAST: CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)       244

TABLE 169         GCC COUNTRIES: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    244

6.2.1.2.9 Contamination detection kits           244

6.2.1.2.9.1           Rapid identification of microbial contaminants to drive usage of contamination detection kits            244

TABLE 170         CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)          245

TABLE 171         NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         245

TABLE 172         EUROPE: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    246

TABLE 173         ASIA PACIFIC: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            246

TABLE 174         LATIN AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         247

TABLE 175         MIDDLE EAST: CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)  247

TABLE 176         GCC COUNTRIES: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         247

6.2.1.2.10            Other reagents     248

TABLE 177         OTHER REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          248

TABLE 178         NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          249

TABLE 179         EUROPE: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 249

TABLE 180         ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          250

TABLE 181         LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          250

TABLE 182         MIDDLE EAST: OTHER REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)     250

TABLE 183         GCC COUNTRIES: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          251

6.2.1.3   Sera       251

TABLE 184         SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)        252

TABLE 185         SERA MARKET, BY REGION, 2022–2029 (USD MILLION)  252

TABLE 186         NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 252

TABLE 187         EUROPE: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          253

TABLE 188         ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          253

TABLE 189         LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          254

TABLE 190         MIDDLE EAST: SERA MARKET, BY REGION, 2022–2029 (USD MILLION)          254

TABLE 191         GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 254

6.2.1.3.1 Fetal bovine sera  255

6.2.1.3.1.1           Fetal bovine sera to hold largest share            255

TABLE 192         FETAL BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)          255

TABLE 193         NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    256

TABLE 194         EUROPE: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     256

TABLE 195         ASIA PACIFIC: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          257

TABLE 196         LATIN AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          257

TABLE 197         MIDDLE EAST: FETAL BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)          257

TABLE 198        GCC COUNTRIES: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          258

6.2.1.3.2 Adult bovine sera 258

6.2.1.3.2.1           Cost-effectiveness and use as a biochemical reagent in IVD to support adoption 258

TABLE 199         ADULT BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)          258

TABLE 200         NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    259

TABLE 201         EUROPE: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     259

TABLE 202         ASIA PACIFIC: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          260

TABLE 203        LATIN AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          260

TABLE 204         MIDDLE EAST: ADULT BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)          260

TABLE 205         GCC COUNTRIES: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    261

6.2.1.3.3 Other animal sera 261

TABLE 206         OTHER ANIMAL SERA MARKET, BY REGION, 2022–2029 (USD MILLION)          262

TABLE 207         NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    262

TABLE 208         EUROPE: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     263

TABLE 209         ASIA PACIFIC: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          263

TABLE 210        LATIN AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          264

TABLE 211         MIDDLE EAST: OTHER ANIMAL SERA MARKET, BY REGION, 2022–2029 (USD MILLION)          264

TABLE 212         GCC COUNTRIES: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    264

6.2.2      VESSELS            265

TABLE 213         VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)  265

TABLE 214         VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)              265

TABLE 215         NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 266

TABLE 216         EUROPE: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          266

TABLE 217         ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          267

TABLE 218         LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 267

TABLE 219         MIDDLE EAST: VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)          267

TABLE 220         GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 268

6.2.2.1   Cell factory systems/cell stacks        268

6.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive end-user adoption 268

TABLE 221         CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)          268

TABLE 222         NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         269

TABLE 223         EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    269

TABLE 224         ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         270

TABLE 225         LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         270

TABLE 226         MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)            271

TABLE 227         GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         271

6.2.2.2   Roller/roux bottles            271

6.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth     271

TABLE 228         ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)          272

TABLE 229         NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    272

TABLE 230         EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          273

TABLE 231         ASIA PACIFIC: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    273

TABLE 232         LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    274

TABLE 233         MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)          274

TABLE 234         GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    274

6.2.2.3   Flasks    275

6.2.2.3.1 Advancements in cell culture flasks to boost segment growth     275

TABLE 235         FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)              275

TABLE 236         NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 276

TABLE 237         EUROPE: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          276

TABLE 238         ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          277

TABLE 239         LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 277

TABLE 240         MIDDLE EAST: FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)          277

TABLE 241         GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 278

6.2.2.4   Multiwell plates   278

6.2.2.4.1 Increased adoption of multiwell plates to drive market 278

TABLE 242         MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)          279

TABLE 243         NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    279

TABLE 244         EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     280

TABLE 245         ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          280

TABLE 246         LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          281

TABLE 247         MIDDLE EAST: MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)          281

TABLE 248        GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          281

6.2.2.5   Petri dishes          282

6.2.2.5.1 Ease of use to drive demand             282

TABLE 249         PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION)              282

TABLE 250         NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     282

TABLE 251         EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 283

TABLE 252         ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 283

TABLE 253         LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     284

TABLE 254         MIDDLE EAST: PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION) 284

TABLE 255         GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     284

6.2.3      ACCESSORIES   285

6.2.3.1   Reduced preparation time and equipment performance improvements to drive market   285

TABLE 256         ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)              285

TABLE 257         NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     285

TABLE 258         EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 286

TABLE 259         ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 286

TABLE 260         LATIN AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     287

TABLE 261         MIDDLE EAST: ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 287

TABLE 262         GCC COUNTRIES: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     287

6.3         EQUIPMENT     288

TABLE 263         EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)              288

TABLE 264         EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)              288

TABLE 265         NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     289

TABLE 266         EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          289

TABLE 267         ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 290

TABLE 268         LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     290

TABLE 269         MIDDLE EAST: EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 290

TABLE 270         GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     291

6.3.1      BIOREACTORS 291

TABLE 271         BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)              291

TABLE 272         BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)          292

TABLE 273         NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          292

TABLE 274         EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 293

TABLE 275         ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     293

TABLE 276         LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     294

TABLE 277         MIDDLE EAST: BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 294

TABLE 278         GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          294

6.3.1.1   Conventional bioreactors   295

6.3.1.1.1 Utilization in large-scale manufacturing of drugs to drive market             295

TABLE 279         CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)     295

TABLE 280         NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            296

TABLE 281         EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    296

TABLE 282         ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    297

TABLE 283         LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    297

TABLE 284         MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)       298

TABLE 285         GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            298

6.3.1.2   Single-use bioreactors       298

6.3.1.2.1 Lower operational costs and increased flexibility to boost demand            298

TABLE 286         LIST OF COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS, BY KEY PLAYER 299

TABLE 287         SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 300

TABLE 288         NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    300

TABLE 289         EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          301

TABLE 290         ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    301

TABLE 291         LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    302

TABLE 292         MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)       302

TABLE 293         GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    302

6.3.2      STORAGE EQUIPMENT 303

TABLE 294         STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          303

TABLE 295         STORAGE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)          303

TABLE 296         NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    304

TABLE 297         EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     304

TABLE 298         ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          305

TABLE 299         LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    305

TABLE 300         MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)          305

TABLE 301         GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    306

6.3.2.1   Refrigerators & freezers     306

6.3.2.1.1 Increasing need for storage solutions to propel market 306

TABLE 302         REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 307

TABLE 303         NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    307

TABLE 304        EUROPE: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          308

TABLE 305         ASIA PACIFIC: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    308

TABLE 306         LATIN AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    309

TABLE 307         MIDDLE EAST: REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION)       309

TABLE 308         GCC COUNTRIES: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    309

6.3.2.2   Cryostorage systems          310

6.3.2.2.1 Benefits of long-term preservation of cell cultures to support growth       310

TABLE 309         CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 311

TABLE 310         NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    311

TABLE 311         EUROPE: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          312

TABLE 312         ASIA PACIFIC: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    312

TABLE 313         LATIN AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    313

TABLE 314         MIDDLE EAST: CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          313

TABLE 315         GCC COUNTRIES: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    313

6.3.3      OTHER EQUIPMENT     314

TABLE 316         OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          314

TABLE 317         OTHER EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)          314

TABLE 318         NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    315

TABLE 319         EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     315

TABLE 320         ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          316

TABLE 321         LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          316

TABLE 322         MIDDLE EAST: OTHER EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)          316

TABLE 323        GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          317

6.3.3.1   Filtration systems 317

6.3.3.1.1 Growing use in bioprocessing industry to boost demand            317

TABLE 324         LIST OF FILTRATION SYSTEMS, BY KEY PLAYER             318

TABLE 325         FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          318

TABLE 326         NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    319

TABLE 327         EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     319

TABLE 328         ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          320

TABLE 329         LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    320

TABLE 330         MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          320

TABLE 331         GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    321

6.3.3.2   Cell counters        321

6.3.3.2.1 Growing adoption of automated cell counters to propel market  321

TABLE 332         LIST OF COMMERCIALLY AVAILABLE CELL COUNTERS, BY KEY PLAYER 321

TABLE 333         CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION)          322

TABLE 334         NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          322

TABLE 335         EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 323

TABLE 336         ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     323

TABLE 337         LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          324

TABLE 338         MIDDLE EAST: CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION)     324

TABLE 339         GCC COUNTRIES: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          324

6.3.3.3   Carbon dioxide incubators 325

6.3.3.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market   325

TABLE 340         CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS           325

TABLE 341         CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)     326

TABLE 342         NORTH AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            326

TABLE 343         EUROPE: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    327

TABLE 344         ASIA PACIFIC: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    327

TABLE 345         LATIN AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    328

TABLE 346         MIDDLE EAST: CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)       328

TABLE 347         GCC COUNTRIES: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            328

6.3.3.4   Centrifuges          329

6.3.3.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges              329

TABLE 348         CENTRIFUGES OFFERED BY KEY MARKET PLAYERS       329

TABLE 349         CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION)              330

TABLE 350         NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          330

TABLE 351         EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 331

TABLE 352         ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     331

TABLE 353         LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     332

TABLE 354         MIDDLE EAST: CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION) 332

TABLE 355         GCC COUNTRIES: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     332

6.3.3.5   Autoclaves           333

6.3.3.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves              333

TABLE 356         AUTOCLAVES MARKET, BY REGION, 2022–2029 (USD MILLION)              333

TABLE 357         NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     333

TABLE 358         EUROPE: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 334

TABLE 359         ASIA PACIFIC: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 334

TABLE 360         LATIN AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     335

TABLE 361         MIDDLE EAST: AUTOCLAVES MARKET, BY REGION, 2022–2029 (USD MILLION) 335

TABLE 362         GCC COUNTRIES: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     335

6.3.3.6   Microscopes        336

6.3.3.6.1 Inverted microscopes to show sustained demand in cell culture processes 336

TABLE 363         MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)          336

TABLE 364         NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          337

TABLE 365         EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 337

TABLE 366         ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     338

TABLE 367         LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     338

TABLE 368         MIDDLE EAST: MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION) 338

TABLE 369         GCC COUNTRIES: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          339

6.3.3.7   Biosafety cabinets 339

6.3.3.7.1 New product launches to drive market           339

TABLE 370         BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS              340

TABLE 371         BIOSAFETY CABINETS MARKET, BY REGION, 2022–2029 (USD MILLION)          340

TABLE 372         NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    341

TABLE 373         EUROPE: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     341

TABLE 374         ASIA PACIFIC: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          342

TABLE 375         LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    342

TABLE 376         MIDDLE EAST: BIOSAFETY CABINETS MARKET, BY REGION, 2022–2029 (USD MILLION)          342

TABLE 377         GCC COUNTRIES: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    343

6.3.3.8   Other supporting equipment           343

TABLE 378         OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS           343

TABLE 379         OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)     344

TABLE 380        NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            344

TABLE 381         EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    345

TABLE 382         ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    345

TABLE 383         LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            346

TABLE 384         MIDDLE EAST: OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)       346

TABLE 385         GCC COUNTRIES: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            346

7            CELL CULTURE MARKET, BY APPLICATION      347

7.1         INTRODUCTION            348

TABLE 386         CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          348

7.2         BIOPHARMACEUTICAL PRODUCTION  348

TABLE 387         CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022–2029 (USD MILLION)  349

TABLE 388         NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          349

TABLE 389         EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             350

TABLE 390         ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          350

TABLE 391         LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          351

TABLE 392         MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022–2029 (USD MILLION)              351

TABLE 393         GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          351

TABLE 394         CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        352

7.2.1      MONOCLONAL ANTIBODY PRODUCTION         352

7.2.1.1   Increasing approval and launch of mAb candidates to drive growth          352

TABLE 395         CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)  353

TABLE 396         NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          353

TABLE 397         EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)      354

TABLE 398         ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)      354

TABLE 399         LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)      355

TABLE 400         MIDDLE EAST: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)          355

TABLE 401         GCC COUNTRIES: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          355

7.2.2      VACCINE PRODUCTION             356

7.2.2.1   Rising incidence of infectious diseases to support market growth             356

TABLE 402         CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2022–2029 (USD MILLION)       357

TABLE 403         NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             357

TABLE 404         EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             358

TABLE 405         ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             358

TABLE 406         LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             359

TABLE 407         MIDDLE EAST: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2022–2029 (USD MILLION)  359

TABLE 408         GCC COUNTRIES: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             359

7.2.3      OTHER THERAPEUTIC PROTEIN PRODUCTION             360

TABLE 409         CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)  360

TABLE 410         NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          361

TABLE 411         EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)         361

TABLE 412         ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          362

TABLE 413         LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          362

TABLE 414         MIDDLE EAST: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)              363

TABLE 415         GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          363

7.3         DIAGNOSTICS  363

7.3.1      ADVANCEMENTS AND ADOPTION OF NEW TECHNIQUES TO DRIVE SEGMENT GROWTH     363

TABLE 416         CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)          364

TABLE 417         NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             364

TABLE 418         EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)    365

TABLE 419         ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)    365

TABLE 420         LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)            366

TABLE 421         MIDDLE EAST: CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)  366

TABLE 422        GCC COUNTRIES: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)            366

7.4         TISSUE ENGINEERING & REGENERATIVE MEDICINE      367

TABLE 423         CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)        368

TABLE 424         NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          368

TABLE 425         EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 369

TABLE 426         ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          369

TABLE 427         LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          370

TABLE 428         MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)          370

TABLE 429         GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          370

TABLE 430         CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             371

7.4.1      CELL & GENE THERAPY 371

7.4.1.1   New product launches and strategic alliances to drive segment growth     371

TABLE 431         CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)       372

TABLE 432         NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)       372

TABLE 433        EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)            373

TABLE 434         ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)       373

TABLE 435         LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)       374

TABLE 436         MIDDLE EAST: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)           374

TABLE 437         GCC COUNTRIES: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)       374

7.4.2      OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS 375

TABLE 438         CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          375

TABLE 439         NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)    376

TABLE 440         EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          376

TABLE 441         ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          377

TABLE 442         LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          377

TABLE 443         MIDDLE EAST: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)     378

TABLE 444         GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)    378

7.5         DRUG SCREENING & DEVELOPMENT    378

7.5.1      INCREASING NEW DRUG DEVELOPMENT ACTIVITIES TO DRIVE MARKET            378

TABLE 445         CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 379

TABLE 446         NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              379

TABLE 447         EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)          380

TABLE 448         ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)      380

TABLE 449         LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              381

TABLE 450         MIDDLE EAST: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)  381

TABLE 451         GCC COUNTRIES: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              381

7.6         OTHER APPLICATIONS 382

TABLE 452         CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       382

TABLE 453         NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           383

TABLE 454        EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            383

TABLE 455         ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           384

TABLE 456         LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           384

TABLE 457         MIDDLE EAST: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 385

TABLE 458         GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           385

8            CELL CULTURE MARKET, BY END USER              386

8.1         INTRODUCTION            387

TABLE 459         CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          387

8.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   387

8.2.1      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD 387

TABLE 460         RECENT DEVELOPMENTS IN PHARMA & BIOTECH SECTOR              388

TABLE 461         CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 388

TABLE 462         NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 389

TABLE 463         EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              389

TABLE 464         ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 390

TABLE 465         LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 390

TABLE 466         MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 391

TABLE 467         GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 391

8.3         HOSPITALS & DIAGNOSTIC LABORATORIES      391

8.3.1      INCREASING DEMAND FOR CELL CULTURE PRODUCTS AND STRATEGIC ACTIVITIES TO DRIVE SEGMENT   391

TABLE 468         CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 392

TABLE 469         NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              392

TABLE 470         EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              393

TABLE 471         ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              393

TABLE 472         LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              394

TABLE 473         MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)   394

TABLE 474         GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              394

8.4         RESEARCH & ACADEMIC INSTITUTES   395

8.4.1      INCREASING FUNDING ACTIVITIES TO DRIVE MARKET 395

TABLE 475         CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)      395

TABLE 476         NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         396

TABLE 477         EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         396

TABLE 478         ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         397

TABLE 479         LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         397

TABLE 480         MIDDLE EAST: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)             398

TABLE 481         GCC COUNTRIES: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         398

8.5         OTHER END USERS        398

TABLE 482         CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)          399

TABLE 483         NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             400

TABLE 484         EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    400

TABLE 485         ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             401

TABLE 486         LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             401

TABLE 487         MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)   402

TABLE 488         GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             402

9            CELL CULTURE MARKET, BY REGION   403

9.1         INTRODUCTION            404

TABLE 489         CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)          404

9.2         NORTH AMERICA          404

9.2.1      NORTH AMERICA: RECESSION IMPACT 405

FIGURE 33         NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT              406

TABLE 490         NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          406

TABLE 491         NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          407

TABLE 492         NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)     407

TABLE 493         NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             407

TABLE 494         NORTH AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          408

TABLE 495         NORTH AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 408

TABLE 496         NORTH AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          409

TABLE 497         NORTH AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          409

TABLE 498         NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 409

TABLE 499         NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 410

TABLE 500         NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          410

TABLE 501         NORTH AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          410

TABLE 502         NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          411

TABLE 503         NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              411

TABLE 504         NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          412

TABLE 505         NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          412

9.2.2      US         413

9.2.2.1   US to hold largest share of North American market      413

TABLE 506         INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2022 413

TABLE 507         US: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          414

TABLE 508         US: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          414

TABLE 509         US: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     414

TABLE 510         US: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              415

TABLE 511         US: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)              415

TABLE 512         US: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION) 416

TABLE 513         US: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              416

TABLE 514         US: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)              416

TABLE 515         US: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          417

TABLE 516         US: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          417

TABLE 517         US: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          417

TABLE 518         US: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 418

TABLE 519         US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        418

TABLE 520         US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             419

TABLE 521         US: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          419

9.2.3      CANADA            420

9.2.3.1   Increasing funding and investments for advancing cell-based therapies to boost market   420

TABLE 522         CANADA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 420

TABLE 523         CANADA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          421

TABLE 524         CANADA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          421

TABLE 525         CANADA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              421

TABLE 526         CANADA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          422

TABLE 527         CANADA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              422

TABLE 528         CANADA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          423

TABLE 529         CANADA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          423

TABLE 530         CANADA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          423

TABLE 531         CANADA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 424

TABLE 532         CANADA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 424

TABLE 533         CANADA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     425

TABLE 534         CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              425

TABLE 535         CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          426

TABLE 536         CANADA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 426

9.3         EUROPE             427

9.3.1      EUROPE: RECESSION IMPACT   427

TABLE 537         EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 428

TABLE 538         EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 428

TABLE 539         EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          428

TABLE 540         EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          429

TABLE 541         EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              429

TABLE 542         EUROPE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          430

TABLE 543         EUROPE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              430

TABLE 544         EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          431

TABLE 545         EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          431

TABLE 546         EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          431

TABLE 547         EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 432

TABLE 548         EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 432

TABLE 549         EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     433

TABLE 550         EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        433

TABLE 551         EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          434

TABLE 552         EUROPE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 434

9.3.2      GERMANY         435

9.3.2.1   Rising R&D investments and strategic alliances to drive market 435

TABLE 553         GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 435

TABLE 554         GERMANY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          436

TABLE 555         GERMANY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          436

TABLE 556         GERMANY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          436

TABLE 557         GERMANY: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          437

TABLE 558         GERMANY: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              437

TABLE 559         GERMANY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          438

TABLE 560         GERMANY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          438

TABLE 561         GERMANY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          438

TABLE 562         GERMANY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     439

TABLE 563         GERMANY: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 439

TABLE 564         GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     440

TABLE 565         GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              440

TABLE 566         GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          441

TABLE 567         GERMANY: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 441

9.3.3      UK         442

9.3.3.1   Growth in life science industry and favorable government investments to support market   442

TABLE 568         UK: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          442

TABLE 569         UK: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          442

TABLE 570         UK: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     443

TABLE 571         UK: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              443

TABLE 572         UK: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)              444

TABLE 573         UK: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION) 444

TABLE 574         UK: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              445

TABLE 575         UK: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)              445

TABLE 576         UK: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          445

TABLE 577         UK: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          446

TABLE 578         UK: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          446

TABLE 579         UK: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 447

TABLE 580         UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        447

TABLE 581         UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             448

TABLE 582         UK: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          448

9.3.4      FRANCE             449

9.3.4.1   Rising number of cell-based research projects to enhance market growth 449

TABLE 583         FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 449

TABLE 584         FRANCE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          449

TABLE 585         FRANCE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          450

TABLE 586         FRANCE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              450

TABLE 587         FRANCE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          451

TABLE 588         FRANCE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              451

TABLE 589         FRANCE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          452

TABLE 590         FRANCE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          452

TABLE 591         FRANCE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          452

TABLE 592         FRANCE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 453

TABLE 593         FRANCE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 453

TABLE 594         FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     454

TABLE 595         FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        454

TABLE 596         FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          455

TABLE 597         FRANCE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 455

9.3.5      ITALY   456

9.3.5.1   Strong government support to enhance R&D activities 456

TABLE 598         ITALY: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          456

TABLE 599         ITALY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          457

TABLE 600         ITALY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     457

TABLE 601         ITALY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              457

TABLE 602         ITALY: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          458

TABLE 603         ITALY: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              458

TABLE 604         ITALY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              459

TABLE 605         ITALY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          459

TABLE 606         ITALY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          459

TABLE 607         ITALY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 460

TABLE 608         ITALY: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          460

TABLE 609         ITALY: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 461

TABLE 610         ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        461

TABLE 611         ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             462

TABLE 612         ITALY: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          462

9.3.6      SPAIN   463

9.3.6.1   Booming biotechnology industry to aid market growth 463

TABLE 613         SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          463

TABLE 614         SPAIN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          463

TABLE 615         SPAIN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     464

TABLE 616         SPAIN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              464

TABLE 617         SPAIN: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          465

TABLE 618         SPAIN: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              465

TABLE 619         SPAIN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              466

TABLE 620         SPAIN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          466

TABLE 621         SPAIN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          466

TABLE 622         SPAIN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 467

TABLE 623         SPAIN: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          467

TABLE 624         SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 468

TABLE 625         SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        468

TABLE 626         SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             469

TABLE 627         SPAIN: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          469

9.3.7      REST OF EUROPE           470

TABLE 628         REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          470

TABLE 629         REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)     470

TABLE 630         REST OF EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             471

TABLE 631         REST OF EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          471

TABLE 632         REST OF EUROPE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 472

TABLE 633         REST OF EUROPE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          472

TABLE 634         REST OF EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          473

TABLE 635         REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 473

TABLE 636         REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 473

TABLE 637         REST OF EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          474

TABLE 638         REST OF EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          474

TABLE 639         REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          475

TABLE 640         REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              475

TABLE 641         REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          476

TABLE 642         REST OF EUROPE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          476

9.4         ASIA PACIFIC    477

9.4.1      ASIA PACIFIC: RECESSION IMPACT        477

FIGURE 34         ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT       478

TABLE 643         ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     479

TABLE 644         ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     479

TABLE 645         ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 479

TABLE 646         ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             480

TABLE 647         ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          480

TABLE 648         ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          481

TABLE 649         ASIA PACIFIC: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          481

TABLE 650         ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          482

TABLE 651         ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          482

TABLE 652         ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 482

TABLE 653         ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     483

TABLE 654         ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     483

TABLE 655         ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          484

TABLE 656         ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              484

TABLE 657         ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          485

TABLE 658         ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)     485

9.4.2      CHINA  485

9.4.2.1   China to register highest growth rate in Asia Pacific market       485

TABLE 659         CHINA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 486

TABLE 660         CHINA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          487

TABLE 661         CHINA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     487

TABLE 662         CHINA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              487

TABLE 663         CHINA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          488

TABLE 664         CHINA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              488

TABLE 665         CHINA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              489

TABLE 666         CHINA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          489

TABLE 667         CHINA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          489

TABLE 668         CHINA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 490

TABLE 669         CHINA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 490

TABLE 670         CHINA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 491

TABLE 671         CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        491

TABLE 672         CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             492

TABLE 673         CHINA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 492

9.4.3      JAPAN  493

9.4.3.1   Rising government initiatives and increasing investments in biotech to drive market   493

TABLE 674         JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 494

TABLE 675         JAPAN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          494

TABLE 676         JAPAN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     494

TABLE 677         JAPAN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              495

TABLE 678         JAPAN: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          495

TABLE 679         JAPAN: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              496

TABLE 680         JAPAN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              496

TABLE 681         JAPAN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          496

TABLE 682         JAPAN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          497

TABLE 683         JAPAN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 497

TABLE 684         JAPAN: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          497

TABLE 685         JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 498

TABLE 686         JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        498

TABLE 687         JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             499

TABLE 688         JAPAN: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          499

9.4.4      INDIA   500

9.4.4.1   Favorable government support and expansion by key cell culture players to augment market growth     500

TABLE 689         INDIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          500

TABLE 690         INDIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          501

TABLE 691         INDIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     501

TABLE 692         INDIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              501

TABLE 693         INDIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          502

TABLE 694         INDIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              502

TABLE 695         INDIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              503

TABLE 696         INDIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          503

TABLE 697         INDIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          503

TABLE 698         INDIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 504

TABLE 699         INDIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          504

TABLE 700         INDIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 505

TABLE 701         INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        505

TABLE 702         INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             506

TABLE 703         INDIA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          506

9.4.5      SOUTH KOREA 507

9.4.5.1   Growing pharmaceutical sector to drive market           507

TABLE 704         SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     507

TABLE 705         SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 508

TABLE 706         SOUTH KOREA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             508

TABLE 707         SOUTH KOREA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          508

TABLE 708         SOUTH KOREA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          509

TABLE 709         SOUTH KOREA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          509

TABLE 710         SOUTH KOREA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          510

TABLE 711         SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 510

TABLE 712         SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 510

TABLE 713         SOUTH KOREA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          511

TABLE 714         SOUTH KOREA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     511

TABLE 715         SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          512

TABLE 716         SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              512

TABLE 717         SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          513

TABLE 718         SOUTH KOREA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)     513

9.4.6      AUSTRALIA       514

9.4.6.1   Increasing prevalence of chronic diseases to drive market          514

TABLE 719         AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 514

TABLE 720         AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 514

TABLE 721         AUSTRALIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          515

TABLE 722         AUSTRALIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          515

TABLE 723         AUSTRALIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          516

TABLE 724         AUSTRALIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          516

TABLE 725         AUSTRALIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          517

TABLE 726         AUSTRALIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          517

TABLE 727         AUSTRALIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          517

TABLE 728         AUSTRALIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     518

TABLE 729         AUSTRALIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 518

TABLE 730         AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     519

TABLE 731         AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              519

TABLE 732         AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          520

TABLE 733         AUSTRALIA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 520

9.4.7      REST OF ASIA PACIFIC  521

TABLE 734        REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          521

TABLE 735         REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          521

TABLE 736        REST OF ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       522

TABLE 737         REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 522

TABLE 738         REST OF ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     523

TABLE 739         REST OF ASIA PACIFIC: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION) 523

TABLE 740         REST OF ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 524

TABLE 741         REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     524

TABLE 742         REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)     524

TABLE 743         REST OF ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             525

TABLE 744         REST OF ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          525

TABLE 745         REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           526

TABLE 746         REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              526

TABLE 747         REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          527

TABLE 748         REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          527

9.5         LATIN AMERICA             528

9.5.1      LATIN AMERICA: RECESSION IMPACT   528

TABLE 749         LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          528

TABLE 750         LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          529

TABLE 751         LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 529

TABLE 752         LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             529

TABLE 753         LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          530

TABLE 754         LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 530

TABLE 755         LATIN AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          531

TABLE 756         LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          531

TABLE 757         LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 531

TABLE 758         LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 532

TABLE 759         LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          532

TABLE 760         LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     532

TABLE 761         LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          533

TABLE 762         LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              533

TABLE 763         LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          534

TABLE 764         LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)     534

9.5.2      BRAZIL 535

9.5.2.1   Rising prevalence of cancer and related research activities to support market growth   535

TABLE 765         BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 535

TABLE 766         BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          536

TABLE 767         BRAZIL: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          536

TABLE 768         BRAZIL: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              536

TABLE 769         BRAZIL: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          537

TABLE 770         BRAZIL: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              537

TABLE 771         BRAZIL: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              538

TABLE 772         BRAZIL: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          538

TABLE 773         BRAZIL: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          538

TABLE 774         BRAZIL: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 539

TABLE 775         BRAZIL: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 539

TABLE 776         BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 540

TABLE 777         BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        540

TABLE 778         BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             541

TABLE 779         BRAZIL: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 541

9.5.3      MEXICO             542

9.5.3.1   Growth in biopharmaceutical market to spur cell culture demand            542

TABLE 780         MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 542

TABLE 781         MEXICO: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          543

TABLE 782         MEXICO: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          543

TABLE 783         MEXICO: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              543

TABLE 784         MEXICO: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          544

TABLE 785         MEXICO: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              544

TABLE 786         MEXICO: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          545

TABLE 787         MEXICO: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          545

TABLE 788         MEXICO: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          545

TABLE 789         MEXICO: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 546

TABLE 790         MEXICO: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 546

TABLE 791         MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     547

TABLE 792         MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        547

TABLE 793         MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          548

TABLE 794         MEXICO: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 548

9.5.4      REST OF LATIN AMERICA          549

TABLE 795         REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   549

TABLE 796         REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          550

TABLE 797         REST OF LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    550

TABLE 798         REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 550

TABLE 799         REST OF LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     551

TABLE 800         REST OF LATIN AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION) 551

TABLE 801         REST OF LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)     552

TABLE 802         REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          552

TABLE 803         REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          552

TABLE 804         REST OF LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             553

TABLE 805         REST OF LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             553

TABLE 806         REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           554

TABLE 807         REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              554

TABLE 808         REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          555

TABLE 809         REST OF LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)             555

9.6         MIDDLE EAST  556

9.6.1      MIDDLE EAST: RECESSION IMPACT       556

TABLE 810         MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION) 556

TABLE 811         MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     557

TABLE 812         MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 557

TABLE 813         MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             557

TABLE 814         MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          558

TABLE 815         MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          558

TABLE 816         MIDDLE EAST: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          559

TABLE 817         MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          559

TABLE 818         MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          559

TABLE 819         MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 560

TABLE 820         MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          560

TABLE 821         MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     560

TABLE 822         MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          561

TABLE 823         MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              561

TABLE 824         MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          562

TABLE 825         MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)     562

9.6.2      GCC COUNTRIES           562

TABLE 826         GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          563

TABLE 827         GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          563

TABLE 828         GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)     563

TABLE 829         GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             564

TABLE 830         GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          564

TABLE 831         GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 565

TABLE 832         GCC COUNTRIES: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          565

TABLE 833         GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          566

TABLE 834         GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 566

TABLE 835         GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 566

TABLE 836         GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          567

TABLE 837         GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          567

TABLE 838         GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          568

TABLE 839         GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              568

TABLE 840         GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          569

TABLE 841         GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          569

9.6.2.1   Saudi Arabia        570

9.6.2.1.1 Increasing focus of key players on expansion to drive market      570

TABLE 842         SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     570

TABLE 843         SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 570

TABLE 844         SAUDI ARABIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)             571

TABLE 845         SAUDI ARABIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          571

TABLE 846         SAUDI ARABIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          572

TABLE 847         SAUDI ARABIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)          572

TABLE 848         SAUDI ARABIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          573

TABLE 849         SAUDI ARABIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 573

TABLE 850         SAUDI ARABIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 573

TABLE 851         SAUDI ARABIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          574

TABLE 852         SAUDI ARABIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     574

TABLE 853         SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          575

TABLE 854         SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              575

TABLE 855         SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          576

TABLE 856         SAUDI ARABIA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)     576

9.6.2.2   UAE      577

9.6.2.2.1 Developments in healthcare infrastructure and growing government initiatives to drive market        577

TABLE 857         UAE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          577

TABLE 858         UAE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          577

TABLE 859         UAE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     578

TABLE 860         UAE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              578

TABLE 861         UAE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)              579

TABLE 862         UAE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              579

TABLE 863         UAE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              580

TABLE 864         UAE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          580

TABLE 865         UAE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          580

TABLE 866         UAE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 581

TABLE 867         UAE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          581

TABLE 868         UAE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 582

TABLE 869         UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        582

TABLE 870         UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             583

TABLE 871         UAE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)          583

9.6.2.3   Rest of GCC Countries      583

TABLE 872         REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   584

TABLE 873         REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          584

TABLE 874         REST OF GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    585

TABLE 875         REST OF GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)     585

TABLE 876         REST OF GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          586

TABLE 877         REST OF GCC COUNTRIES: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION) 586

TABLE 878         REST OF GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)     587

TABLE 879         REST OF GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          587

TABLE 880         REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          587

TABLE 881         REST OF GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)       588

TABLE 882         REST OF GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             588

TABLE 883         REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           589

TABLE 884         REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              589

TABLE 885         REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          590

TABLE 886         REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)             590

9.6.3      REST OF MIDDLE EAST 591

TABLE 887         REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   591

TABLE 888         REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          591

TABLE 889         REST OF MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    592

TABLE 890         REST OF MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 592

TABLE 891         REST OF MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     593

TABLE 892         REST OF MIDDLE EAST: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION) 593

TABLE 893         REST OF MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 594

TABLE 894         REST OF MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     594

TABLE 895         REST OF MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          594

TABLE 896         REST OF MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             595

TABLE 897         REST OF MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             595

TABLE 898         REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           596

TABLE 899         REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              596

TABLE 900         REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          597

TABLE 901         REST OF MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)             597

9.7         AFRICA 598

9.7.1      RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FUEL MARKET GROWTH            598

9.7.2      AFRICA: RECESSION IMPACT     598

TABLE 902         AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 599

TABLE 903         AFRICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          599

TABLE 904         AFRICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          599

TABLE 905         AFRICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              600

TABLE 906         AFRICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          600

TABLE 907         AFRICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)              601

TABLE 908         AFRICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              601

TABLE 909         AFRICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          601

TABLE 910         AFRICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          602

TABLE 911         AFRICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 602

TABLE 912         AFRICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 602

TABLE 913         AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 603

TABLE 914         AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        603

TABLE 915         AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             604

TABLE 916         AFRICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION) 604

10          COMPETITIVE LANDSCAPE       605

10.1       INTRODUCTION            605

10.2       STRATEGIES ADOPTED BY KEY PLAYERS           605

TABLE 917         STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, 2022−2024     605

10.3       REVENUE SHARE ANALYSIS       607

FIGURE 35         REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2019–2023 (USD BILLION)       607

10.4       MARKET SHARE ANALYSIS         608

FIGURE 36         CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)   608

TABLE 918         CELL CULTURE MARKET: DEGREE OF COMPETITION   609

10.5       BRAND/PRODUCT COMPARATIVE ANALYSIS    611

FIGURE 37         BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT              611

10.5.1    THERMO FISHER SCIENTIFIC INC.          611

10.5.2    DANAHER CORPORATION         612

10.5.3    MERCK KGAA   612

10.5.4    SARTORIUS AG 612

10.5.5    CORNING INCORPORATED       612

10.6       COMPANY EVALUATION MATRIX: KEY PLAYERS            613

10.6.1    STARS  613

10.6.2    EMERGING LEADERS    613

10.6.3    PERVASIVE PLAYERS     613

10.6.4    PARTICIPANTS 613

FIGURE 38         CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023     614

10.6.5    COMPANY FOOTPRINT: KEY PLAYERS  615

FIGURE 39         CELL CULTURE MARKET: COMPANY FOOTPRINT          615

TABLE 919         CELL CULTURE MARKET: PRODUCT FOOTPRINT          616

TABLE 920         CELL CULTURE MARKET: APPLICATION FOOTPRINT   617

TABLE 921         CELL CULTURE MARKET: END-USER FOOTPRINT          618

TABLE 922         CELL CULTURE MARKET: REGIONAL FOOTPRINT         619

10.7       COMPANY EVALUATION MATRIX: STARTUPS/SMES      620

10.7.1    PROGRESSIVE COMPANIES       620

10.7.2    RESPONSIVE COMPANIES          620

10.7.3    DYNAMIC COMPANIES 620

10.7.4    STARTING BLOCKS       620

FIGURE 40         CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023             621

10.7.5    COMPETITIVE BENCHMARKING OF STARTUPS/SMES   622

TABLE 923         CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS            622

TABLE 924         CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES   623

10.8       VALUATION AND FINANCIAL METRICS OF CELL CULTURE VENDORS              623

FIGURE 41         EV/EBITDA OF KEY VENDORS   623

FIGURE 42         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 624

10.9       COMPETITIVE SCENARIO          624

10.9.1    PRODUCT LAUNCHES  624

TABLE 925         CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2024    624

10.9.2    DEALS  625

TABLE 926         CELL CULTURE MARKET: DEALS, JANUARY 2021–FEBRUARY 2024      625

10.9.3    EXPANSIONS    626

TABLE 927         CELL CULTURE MARKET: EXPANSIONS, JANUARY 2021–FEBRUARY 2024 626

11          COMPANY PROFILES    628

11.1       INTRODUCTION            628

11.2       KEY PLAYERS   628

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

11.2.1    THERMO FISHER SCIENTIFIC INC.          628

TABLE 928         THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW              628

FIGURE 43         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT              629

TABLE 929         THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED              629

TABLE 930         THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES              644

TABLE 931         THERMO FISHER SCIENTIFIC INC.: DEALS          645

TABLE 932         THERMO FISHER SCIENTIFIC INC.: EXPANSIONS            645

11.2.2    DANAHER CORPORATION         649

TABLE 933         DANAHER CORPORATION: BUSINESS OVERVIEW           649

FIGURE 44         DANAHER CORPORATION: COMPANY SNAPSHOT         650

TABLE 934         DANAHER CORPORATION: PRODUCTS OFFERED          650

TABLE 935         DANAHER CORPORATION: PRODUCT LAUNCHES         661

TABLE 936         DANAHER CORPORATION: DEALS         661

TABLE 937         DANAHER CORPORATION: EXPANSIONS           663

TABLE 938         DANAHER CORPORATION: OTHER DEVELOPMENTS    664

11.2.3    MERCK KGAA   665

TABLE 939         MERCK KGAA: BUSINESS OVERVIEW     665

FIGURE 45         MERCK KGAA: COMPANY SNAPSHOT    666

TABLE 940         MERCK KGAA: PRODUCTS OFFERED     666

TABLE 941         MERCK KGAA: PRODUCT LAUNCHES    673

TABLE 942         MERCK KGAA: DEALS   673

TABLE 943         MERCK KGAA: EXPANSIONS      674

11.2.4    SARTORIUS AG 676

TABLE 944         SARTORIUS AG: BUSINESS OVERVIEW   676

FIGURE 46         SARTORIUS AG: COMPANY SNAPSHOT 677

TABLE 945         SARTORIUS AG: PRODUCTS OFFERED  677

TABLE 946         SARTORIUS AG: PRODUCT LAUNCHES 684

TABLE 947         SARTORIUS AG: DEALS 684

TABLE 948         SARTORIUS AG: EXPANSIONS   687

11.2.5    CORNING INCORPORATED       688

TABLE 949         CORNING INCORPORATED: BUSINESS OVERVIEW         688

FIGURE 47         CORNING INCORPORATED: COMPANY SNAPSHOT       689

TABLE 950         CORNING INCORPORATED: PRODUCTS OFFERED         689

TABLE 951         CORNING INCORPORATED: PRODUCT LAUNCHES        699

TABLE 952         CORNING INCORPORATED: DEALS       699

11.2.6    FUJIFILM HOLDINGS CORPORATION    700

TABLE 953         FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW              700

FIGURE 48         FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT              701

TABLE 954         FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED              701

TABLE 955         FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES              708

TABLE 956         FUJIFILM HOLDINGS CORPORATION: DEALS    708

TABLE 957         FUJIFILM HOLDINGS CORPORATION: EXPANSIONS       708

11.2.7    BD         710

TABLE 958         BD: BUSINESS OVERVIEW          710

FIGURE 49         BD: COMPANY SNAPSHOT         711

TABLE 959         BD: PRODUCTS OFFERED          711

TABLE 960         BD: PRODUCT LAUNCHES         713

TABLE 961         BD: DEALS        713

11.2.8    EPPENDORF SE 714

TABLE 962         EPPENDORF SE: BUSINESS OVERVIEW  714

FIGURE 50         EPPENDORF SE: COMPANY SNAPSHOT 715

TABLE 963         EPPENDORF SE: PRODUCTS OFFERED  715

TABLE 964         EPPENDORF SE: PRODUCT LAUNCHES 720

TABLE 965         EPPENDORF SE: DEALS 721

TABLE 966         EPPENDORF SE: EXPANSIONS   721

11.2.9    LONZA 723

TABLE 967         LONZA: BUSINESS OVERVIEW   723

FIGURE 51         LONZA: COMPANY SNAPSHOT 724

TABLE 968         LONZA: PRODUCTS OFFERED  724

TABLE 969         LONZA: PRODUCT LAUNCHES 727

TABLE 970         LONZA: DEALS 728

11.2.10  GETINGE AB     729

TABLE 971         GETINGE AB: BUSINESS OVERVIEW       729

FIGURE 52         GETINGE AB: COMPANY SNAPSHOT     730

TABLE 972         GETINGE AB: PRODUCTS OFFERED      730

TABLE 973         GETINGE AB: PRODUCT LAUNCHES     731

TABLE 974         GETINGE AB: DEALS     732

TABLE 975         GETINGE AB: EXPANSIONS        732

11.2.11  AGILENT TECHNOLOGIES, INC.             733

TABLE 976         AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 733

FIGURE 53         AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 734

TABLE 977         AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 734

TABLE 978         AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES 736

TABLE 979         AGILENT TECHNOLOGIES, INC.: DEALS             736

11.2.12  HIMEDIA LABORATORIES          737

TABLE 980         HIMEDIA LABORATORIES: BUSINESS OVERVIEW            737

TABLE 981         HIMEDIA LABORATORIES: PRODUCTS OFFERED           737

11.2.13  BIO-TECHNE    741

TABLE 982         BIO-TECHNE: COMPANY OVERVIEW     741

FIGURE 54         BIO-TECHNE: COMPANY SNAPSHOT     742

TABLE 983         BIO-TECHNE: PRODUCTS OFFERED      742

TABLE 984         BIO-TECHNE: PRODUCT LAUNCHES     746

TABLE 985         BIO-TECHNE: DEALS    746

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies

11.3       OTHER PLAYERS           747

11.3.1    MILTENYI BIOTEC         747

TABLE 986         MILTENYI BIOTEC: BUSINESS OVERVIEW           747

11.3.2    STEMCELL TECHNOLOGIES      750

TABLE 987         STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW        750

11.3.3    SOLIDA BIOTECH GMBH            753

TABLE 988         SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW 753

11.3.4    CAISSON LABS INC.        754

TABLE 989         CAISSON LABS INC.: BUSINESS OVERVIEW         754

11.3.5    PROMOCELL GMBH      755

TABLE 990         PROMOCELL GMBH: BUSINESS OVERVIEW        755

11.3.6    INVIVOGEN      756

TABLE 991         INVIVOGEN: BUSINESS OVERVIEW        756

11.3.7    PAN-BIOTECH  757

TABLE 992         PAN-BIOTECH: BUSINESS OVERVIEW    757

11.3.8    CELLEXUS         758

TABLE 993         CELLEXUS: BUSINESS OVERVIEW           758

11.3.9    MEISSNER FILTRATION PRODUCTS, INC.           759

TABLE 994         MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW        759

11.3.10  ADOLF KÜHNER AG      761

TABLE 995         ADOLF KÜHNER AG: BUSINESS OVERVIEW        761

11.3.11  ADVANCION CORPORATION    762

TABLE 996         ADVANCION CORPORATION: BUSINESS OVERVIEW      762

11.3.12  BIOSPHERIX, LTD.         763

TABLE 997         BIOSPHERIX, LTD.: BUSINESS OVERVIEW           763

12          APPENDIX         764

12.1       DISCUSSION GUIDE      764

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             768

12.3       CUSTOMIZATION OPTIONS      770

12.4       RELATED REPORTS       771

12.5       AUTHOR DETAILS         772